Trial Profile
Pharmacokinetic and drug-food interaction trial to evaluate abuse-resistant hydrocodone/paracetamol formulated with Aversion Technology.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2014
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 29 Sep 2014 Preliminary results published in an Acura Pharmaceuticals media release.
- 29 Sep 2014 Primary endpoint (Blood concentrations; bioequivalence in fed and fasted states) has been met, according to an Acura Pharmaceuticals media release.
- 29 Sep 2014 Status changed from planning to completed, according to an Acura Pharmaceuticals media release.